Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault

被引:63
|
作者
Bamberger, JD
Waldo, CR
Gerberding, JL
Katz, MH
机构
[1] Univ Calif San Francisco, San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA
[2] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[4] Univ Calif San Francisco, Ctr Aids Prevent Studies, San Francisco, CA 94143 USA
[5] Ctr Dis Control & Prevent, Hosp Infect Program, Atlanta, GA USA
来源
AMERICAN JOURNAL OF MEDICINE | 1999年 / 106卷 / 03期
关键词
D O I
10.1016/S0002-9343(99)00018-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the 1998 Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases recommend offering postexposure prophylaxis for human immunodeficiency virus (HN) infection following sexual assault, there are no detailed protocols on how to provide this treatment. Postexposure prophylaxis has been shown to lower the risk of seroconversion following occupational exposure to HIV by 81%, but has not yet been evaluated following sexual exposure. Though scientific data are limited, victims of sexual assault should be given the best information available to make an informed decision regarding postexposure prophylaxis. When the choice is made to take medications to prevent HIV infection, treatment should be initiated as soon as possible, but no later than 72 hours following the assault, and should be continued for 28 days. HIV postexposure prophylaxis should be provided in the context of a comprehensive treatment and counseling program that recognizes the physical and psychosocial trauma experienced by victims of sexual assault. (C) 1999 by Excerpta Medica, Inc.
引用
收藏
页码:323 / 326
页数:4
相关论文
共 50 条
  • [21] HIV Postexposure Prophylaxis After Sexual Assault: Why Is It So Hard to Accomplish?
    Cohen, Myron S.
    SEXUALLY TRANSMITTED DISEASES, 2008, 35 (12) : 979 - 980
  • [22] Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus
    Jochimsen, EM
    Luo, CC
    Beltrami, JF
    Respess, RA
    Schable, CA
    Cardo, DM
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (19) : 2361 - 2363
  • [23] The awareness of postexposure prophylaxis for HIV infection following sexual exposure in emergency departments in a regional HIV network
    Rutland, E.
    Sundaram, S.
    Mani, R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (09) : 636 - 637
  • [24] Postexposure Prophylaxis for HIV Infection
    Landovitz, Raphael J.
    Currier, Judith S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1768 - 1775
  • [25] Human immunodeficiency virus prophylaxis for sexual assault survivors - What we need to know
    Ellen, JM
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (07): : 754 - 755
  • [26] Postexposure Prophylaxis Against Human Immunodeficiency Virus (HIV): New Guidelines From the WHO: A Perspective
    Kaplan, Jonathan E.
    Dominguez, Kenneth
    Jobarteh, Kebba
    Spira, Thomas J.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 : S196 - S199
  • [27] Current Practice of HIV Postexposure Prophylaxis Treatment for Sexual Assault Patients in an Emergency Department
    Krause, Kathleen H.
    Lewis-O'Connor, Annie
    Berger, Amanda
    Votto, Teress
    Yawetz, Sigal
    Pallin, Daniel J.
    Baden, Lindsey R.
    WOMENS HEALTH ISSUES, 2014, 24 (04) : E407 - E412
  • [28] HIV nonoccupational postexposure prophylaxis for sexual assault cases: a 3-year investigation
    Shipeolu, Lolade
    Sampsel, Kari
    Reeves, Allegra
    Blaskovits, Farriss
    Heimerl, Melissa
    Muldoon, Katherine
    AIDS, 2020, 34 (06) : 869 - 876
  • [29] Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: Identification and characterization of the source of exposure
    Roland, ME
    Martin, JN
    Grant, RM
    Hellmann, NS
    Bamberger, JD
    Katz, MH
    Chesney, M
    Franses, K
    Coates, TJ
    Kahn, JO
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (12): : 1608 - 1612
  • [30] Improving Emergency Access to Human Immunodeficiency Virus Prophylaxis for Patients Evaluated After Sexual Assault
    Saadatzadeh, Tirajeh
    Salas, Natalie M.
    Walraven, Carla
    Sarangarm, Preeyaporn
    Crandall, Cameron S.
    Crook, Joy
    Sarangarm, Dusadee
    Yaple, Charles
    Stafford, Amanda
    Wilson, Christopher G.
    Page, Kimberly
    Carvour, Martha L.
    JOURNAL FOR HEALTHCARE QUALITY, 2021, 43 (02) : 82 - 91